UNIVERSITY OF WISCONSIN-MADISON
Toward vocal fold scar mitigation through CRISPR/Cas-9-mediated gene editing of fibroblasts
Toward vocal fold scar mitigation through CRISPR/Cas-9-mediated gene editing of fibroblasts is a funding opportunity from UNIVERSITY OF WISCONSIN-MADISON, up to 52538, closing August 21, 2027.
Aug 21, 2027
(386d left)Overview
ABSTRACT Vocal fold (VF) scarring negatively impacts both voice quality and quality of life, and effective treatments are currently lacking. VF fibroblasts (VFF) play a crucial role in VF scarring, as they are involved in wound healing and the production and remodeling of the VF lamina propria extracellular matrix in…